Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fascia is an extensive network of connective tissue that envelops and supports all structures and organs throughout the human body—including muscles, nerves, blood vessels, tendons, ligaments, bones, and internal organs. It is composed primarily of collagen fibers interspersed with elastin fibers within an extracellular matrix rich in hyaluronan (hyaluronic acid) and proteoglycans. This structure provides both strength and flexibility while enabling smooth gliding between adjacent tissues. There are several types of fascia: - **Superficial fascia**, located just beneath the skin; - **Deep fascia**, which surrounds muscles/bones/tendons/nerves; - **Visceral fascia**, supporting internal organs; - **Parietal fascia**, lining body cavities. The main cellular components include fibroblasts (which produce collagen), myofibroblasts (with contractile properties), adipocytes (fat storage), fasciacytes (produce hyaluronic acid), telocytes (cellular communication), macrophages/mast cells/other immune cells[2][5][7]. Functionally, the fascial system maintains structural integrity by distributing mechanical forces across the body during movement while reducing friction between moving parts. It also plays roles in joint stability/circulation/shock absorption/intercellular signaling. While crucial for normal physiology—and implicated secondarily in conditions like chronic pain syndromes or fibrosis—fascia itself is not considered a classical therapeutic "target" such as receptors or enzymes would be.[1][2][3] Fascia is *not* a single molecule/receptor/enzyme/transporter but rather an anatomical structure/system made up primarily of extracellular matrix proteins—mainly collagen—and various cell types embedded within it.[1] Therefore: - It does *not* fit standard definitions for drug targets used in pharmacology/therapeutics. - No canonical abbreviation exists beyond its full name ("fascia"). - No direct interacting drugs/mechanisms/biomarkers/safety concerns apply at the molecular level. If you are seeking information about specific molecules within the fascial system—such as particular collagens or cell surface receptors expressed by fibroblasts—please specify further so that structured data can be provided at that level.
Not applicable; no known drugs directly target fascia as a molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fascia.